A carregar...
Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
BACKGROUND: Hemolysis is an infrequent but recognized and potentially serious adverse effect of intravenous immunoglobulin (IVIG). Relatively elevated hemolysis reporting rates were seen with some IVIG products with high anti‐A/B isoagglutinin content, among which IgPro10 (Privigen, CSL Behring). Fo...
Na minha lista:
| Publicado no: | Transfusion |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383922/ https://ncbi.nlm.nih.gov/pubmed/32410287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/trf.15846 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|